These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 33544387)
21. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids: part 1. Which test should be used? Zöllner EW Pediatr Allergy Immunol; 2007 Aug; 18(5):401-9. PubMed ID: 17561933 [TBL] [Abstract][Full Text] [Related]
22. Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®). Quantz K; Anderson AL; Harman CD; Noland EL; Del Valle JM; Occelli LM; Burn JB; Petersen-Jones SM; Langlois DK; Pirie CG; Petersen AD; Komáromy AM BMC Vet Res; 2021 Dec; 17(1):366. PubMed ID: 34847929 [TBL] [Abstract][Full Text] [Related]
23. Lysine-vasopressin in the evaluation of the hypothalamic-pituitary-adrenal axis in children with allergic rhinitis treated with intranasal beclomethasone dipropionate or oral prednisone. Kokron CM; Castro AS; Solé D; Naspitz CK J Investig Allergol Clin Immunol; 1997; 7(1):51-6. PubMed ID: 9093935 [TBL] [Abstract][Full Text] [Related]
25. Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis. Lucky AW; Grote GD; Williams JL; Tuley MR; Czernielewski JM; Dolak TM; Herndon JH; Baker MD Cutis; 1997 Mar; 59(3):151-3. PubMed ID: 9071556 [TBL] [Abstract][Full Text] [Related]
26. Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial. Then Bergh F; Kümpfel T; Grasser A; Rupprecht R; Holsboer F; Trenkwalder C J Clin Endocrinol Metab; 2001 Apr; 86(4):1610-5. PubMed ID: 11297592 [TBL] [Abstract][Full Text] [Related]
27. New insights into the role of perinatal HPA-axis dysregulation in postpartum depression. Glynn LM; Davis EP; Sandman CA Neuropeptides; 2013 Dec; 47(6):363-70. PubMed ID: 24210135 [TBL] [Abstract][Full Text] [Related]
28. The hypothalamic-pituitary-adrenal axis in asthmatic children. Priftis KN; Papadimitriou A; Nicolaidou P; Chrousos GP Trends Endocrinol Metab; 2008 Jan; 19(1):32-8. PubMed ID: 18155557 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of hypothalamic-pituitary-adrenal axis suppression in children treated for asthma with inhaled corticosteroid. Smith RW; Downey K; Gordon M; Hudak A; Meeder R; Barker S; Smith WG Paediatr Child Health; 2012 May; 17(5):e34-9. PubMed ID: 23633903 [TBL] [Abstract][Full Text] [Related]
30. Inhaled corticosteroids and HPA axis suppression: how important is it and how should it be managed? Rao Bondugulapati LN; Rees DA Clin Endocrinol (Oxf); 2016 Aug; 85(2):165-9. PubMed ID: 27038017 [TBL] [Abstract][Full Text] [Related]
31. Inhaled corticosteroids: Ocular safety and the hypothalamic-pituitary-adrenal axis. Carr WW; Szefler SJ Ann Allergy Asthma Immunol; 2016 Dec; 117(6):589-594. PubMed ID: 27979014 [TBL] [Abstract][Full Text] [Related]
32. Predictive modeling of the hypothalamic-pituitary-adrenal (HPA) axis response to acute and chronic stress. Marković VM; Čupić Ž; Vukojević V; Kolar-Anić L Endocr J; 2011; 58(10):889-904. PubMed ID: 21852742 [TBL] [Abstract][Full Text] [Related]
33. Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Dallman MF; Strack AM; Akana SF; Bradbury MJ; Hanson ES; Scribner KA; Smith M Front Neuroendocrinol; 1993 Oct; 14(4):303-47. PubMed ID: 8258378 [TBL] [Abstract][Full Text] [Related]